Western Asset Management Company’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-16
Closed -$5K 60
2020
Q2
$5K Buy
+16
New +$4.81K ﹤0.01% 58

Other funds holding BIIB

Western Asset Management Company's BIIB Position: Q3 2020 in Review

Western Asset Management Company sold out of Biogen (BIIB) in Q3 2020, closing a stake of 16 shares — an estimated $5K sold.

Western Asset Management Company first reported a position in BIIB in Q2 2020 and held it in 1 quarter. The position peaked at $5K in Q2 2020. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Western Asset Management Company reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • Western Asset Management Company sold 16 Biogen shares in Q3 2020, an estimated $5K.
  • Western Asset Management Company first reported a position in Biogen in Q2 2020 and held it in 1 quarter.
  • Western Asset Management Company's Biogen position peaked at $5K in Q2 2020.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Western Asset Management Company's 13F filing for Q3 2020, filed 12 Nov 2020.